National Research Corp (NRC)

Featured in Small-Cap Stocks

National Research Corp. is a healthcare analytics and insights company focused on helping U.S. healthcare organizations measure and improve the experiences of patients, employees, and consumers. Its offerings include market experience tools for monitoring awareness, brand perception, and community segmentation; patient experience software for collecting and analyzing data across care settings; and employee experience solutions covering engagement, culture of safety, and satisfaction tracking. The company also provides consumer reputation and listening tools through nGage, along with Huey, an AI engine designed to support healthcare experience management. In addition, National Research Corp. serves not-for-profit health system boards, executives, and physician leaders through governance-related conferences, publications, advisory services, and an online portal. Founded in 1981, the company is headquartered in Lincoln, Nebraska, and its common stock is listed on NASDAQ under the symbol NRC.


Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NASDAQ-NRC
$19.58
-7.0% Downside
Fair
$23
9.2% Upside
Fair
Fair
0.64
3.0%
July 28, 2026
55.3x
35.2x
3.4x
482.5 M
550.6 M
13.9%
54.3%
5.1
131.0%
202.8%
Valuation • Fair Value

National Research Corp (NASDAQ-NRC) Fair Value by Valuation Model

Compare the primary fair value estimate for National Research Corp (NASDAQ-NRC) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$19.58

Estimated downside of 7.0% versus the current market price.

Fair Value Confidence

High

Confidence level for the primary fair value estimate.

DCF Fair Value

$22.43

Discounted cash flow valuation reference.

Ben Graham Formula Value

$4.23

Classic Ben Graham valuation formula reference.

DDM Fair Value

$11.63

Dividend discount model valuation reference.

EPV Fair Value

$11.53

Earnings power value estimate.

Comps Fair Value

$20.73

Comparable-company valuation reference.

Analyst Price Target

$23

Analysts imply upside of 9.2%.

How to read these valuation models

Use this section to compare the primary fair value estimate for National Research Corp (NASDAQ-NRC) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for National Research Corp (NASDAQ-NRC)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

138.6 M

Current operating scale indicator.

Revenue Forecast

142 M

Forward revenue estimate.

EBITDA

34.602 M

Current operating profitability reference.

EBITDA Forecast

39 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review National Research Corp (NASDAQ-NRC) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for National Research Corp (NASDAQ-NRC)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Fair

Mixed or neutral financial-health read.

Piotroski Score

5

Mid-range quality score.

Beneish M-Score

-3.27

No elevated caution signal from this screen.

Altman Z-Score

5.1

Relatively strong balance-sheet zone.

FCF / Net Income

202.8%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for National Research Corp (NASDAQ-NRC). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for National Research Corp (NASDAQ-NRC)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

July 28, 2026

Days to Earnings

7

Dividend Payment Date

Not available

Ex-Dividend Date

Not available

Dividend Yield

3.0%

Income yield reference.

Upcoming Dividend

0.64

Upcoming distribution amount.

Payment Type

Not available

Data is currently unavailable.

Dividend Currency

USD

Currency used for the distribution.

Payout Ratio

131.0%

Dividend payout reference.

How to read events and dividends

This section helps investors track time-sensitive items for National Research Corp (NASDAQ-NRC), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

National Research Corp (NASDAQ-NRC) Stock Forecast & Technical Outlook

Review National Research Corp (NASDAQ-NRC) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for National Research Corp (NASDAQ-NRC) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for National Research Corp (NASDAQ-NRC) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Sell

The daily technical read for National Research Corp (NASDAQ-NRC) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Buy

The weekly technical read for National Research Corp (NASDAQ-NRC) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Buy

The monthly technical read for National Research Corp (NASDAQ-NRC) is currently Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for National Research Corp (NASDAQ-NRC)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Not available

Analyst recommendation data for National Research Corp (NASDAQ-NRC) is not currently available.

Buy 0
Hold 0
Sell 0
FAQ Fast Investor Answers

National Research Corp (NASDAQ-NRC) Stock FAQ

Quick answers about National Research Corp (NASDAQ-NRC) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$19.58
Estimated downside 7.0%
Valuation Rating
Overvalued
Estimated downside of 7.0%
Analyst Target
$23
Implied upside 9.2%
Financial Health
Fair
Current financial-health read

The current fair value estimate for National Research Corp (NASDAQ-NRC) is $19.58. This implies an estimated downside of 7.0% versus the current market price.

Based on the current fair value estimate, the stock appears overvalued, with estimated downside of 7.0% versus the current market price.

The available analyst price target for National Research Corp (NASDAQ-NRC) is $23. The analyst target implies estimated upside of 9.2%.

The current financial health read for National Research Corp (NASDAQ-NRC) is Fair. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for National Research Corp (NASDAQ-NRC) is July 28, 2026.

Based on the current data, dividend yield is 3.0%, upcoming dividend amount is 0.64.

The current P/E ratio listed for National Research Corp (NASDAQ-NRC) is 55.3x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for National Research Corp is 482.5 M.

The current enterprise value listed for National Research Corp is 550.6 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for National Research Corp is NASDAQ-NRC, and the stock is listed on NASDAQ.

National Research Corp (NASDAQ-NRC) is listed on NASDAQ.

The current debt-to-total-capital ratio listed for National Research Corp is 13.9%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for National Research Corp is 54.3%. Free float helps investors understand how much of the share base is available for public trading.